Procedural sedation: A review of sedative agents, monitoring, and management of complications

Joseph D Tobias, Marc Leder, Joseph D Tobias, Marc Leder

Abstract

Given the continued increase in the complexity of invasive and noninvasive procedures, healthcare practitioners are faced with a larger number of patients requiring procedural sedation. Effective sedation and analgesia during procedures not only provides relief of suffering, but also frequently facilitates the successful and timely completion of the procedure. However, any of the agents used for sedation and/or analgesia may result in adverse effects. These adverse effects most often affect upper airway patency, ventilatory function or the cardiovascular system. This manuscript reviews the pharmacology of the most commonly used agents for sedation and outlines their primary effects on respiratory and cardiovascular function. Suggested guidelines for the avoidance of adverse effects through appropriate pre-sedation evaluation, early identification of changes in respiratory and cardiovascular function, and their treatment are outlined.

Keywords: Dexmedetomidine; ketamine; procedural sedation; propofol; respiratory depression.

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Malviya S, Voepel-Lewis T, Tait AR. Adverse events and risk factors associated with the sedation of children by non-anesthesiologists. Anesth Analg. 1997;85:1207–13.
    1. Hertzog JH, Campbell JK, Dalton HJ, Hauser GJ. Propofol anesthesia for invasive procedures in ambulatory and hospitalized children: Experience in the pediatric intensive care unit. Pediatrics. 1999;103:e30.
    1. Pomeranz ES, Chudnofsky CR, Deegan TJ, Lozon MM, Mitchiner JC, Weber JE. Rectal methohexital sedation for computed tomography imaging of stable pediatric emergency department patients. Pediatrics. 2000;105:1110–4.
    1. Litman RS. Conscious sedation with remifentanil and midazolam during brief painful procedures in children. Arch Pediatr Adolesc Med. 1999;153:1085–8.
    1. Satoh M, Minami M. Molecular pharmacology of the opioid receptors. Pharmacol Ther. 1995;68:343–64.
    1. Bailey PL, Pace NL, Ashburn MA, Moll JW, East KA, Stanley TH. Frequent hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology. 1990;73:826–30.
    1. Yaster M, Nichols DG, Deshpande JK, Wetzel RC. Midazolam-fentanyl intravenous sedation in children: Case report of respiratory arrest. Pediatrics. 1990;86:463–7.
    1. Fahnenstich H, Steffan J, Kau N, Bartmann P. Fentanyl-induced chest wall rigidity and laryngospasm in preterm and term infants. Crit Care Med. 2000;28:835–9.
    1. Muller P, Vogtmann C. Three cases with different presentation of fentanyl-induced muscle rigidity-a rare problem in intensive care of neonates. Am J Perinatol. 2000;17:23–6.
    1. Hershey LA. Meperidine and central neurotoxicity. Ann Intern Med. 1983;98:548–9.
    1. Da Silva O, Alexandrou D, Knoppert D, Young GB. Seizure and electroencephalographic changes in the newborn period induced by opiates and corrected by naloxone infusion. J Perinatol. 1999;19:120–3.
    1. De Armendi AJ, Fahey M, Ryan JF. Morphine-induced myoclonic movements in a pediatric pain patient. Anesth Analg. 1993;77:191–2.
    1. Scott JC, Sarnquist FH. Seizure-like movements during a fentanyl infusion with absence of seizure activity in a simultaneous EEG recording. Anesthesiology. 1985;62:812–4.
    1. Blair JM, Hill DA. Probable seizure after remifentanil in a 4-year-old boy. Anaesthesia. 2000;55:501–3.
    1. Grossmann M, Abiose A, Tangphao O, Blaschke TF, Hoffman BB. Morphine-induced venodilation in humans. Clin Pharmacol Ther. 1996;60:554–60.
    1. Sato A, Sato Y, Schmidt RF. Modulation of somatocardiac sympathetic reflexes mediated by opioid receptors at the spinal and brainstem level. Exp Brain Res. 1995;105:1–6.
    1. Harris CE, Grounds RM, Murray AM, Lumley J, Royston D, Morgan M. Propofol for long-term sedation in the intensive care unit.A comparison with papaveretum and midazolam. Anaesthesia. 1990;45:366–72.
    1. Beller JP, Pottecher T, Lugnier A, Mangin P, Otteni JC. Prolonged sedation with propofol in ICU patients: Recovery and blood concentration changes during periodic interruption in infusion. Br J Anaesth. 1988;61:583–8.
    1. Hemelrijck JV, Fitch W, Mattheussen M, Van Aken H, Plets C, Lauwers T. Effect of propofol on cerebral circulation and autoregulation in the baboon. Anesth Analg. 1990;71:49–54.
    1. Nimkoff L, Quinn C, Silver P, Sagy M. The effects of intravenous anesthetic agents on intracranial pressure and cerebral perfusion pressure in two feline models of brain edema. J Crit Care. 1997;12:132–6.
    1. Kassam SI, Lu C, Buckley N, Lee RM. The mechanisms of propofol-induced vascular relaxation and modulation by perivascular adipose tissue and endothelium. Anesth Analg. 2011;112:1339–45.
    1. Tritapepe L, Voci P, Marino P, Cogliati AA, Rossi A, Bottari B, et al. Calcium chloride minimizes the hemodynamic effects of propofol in patients undergoing coronary artery bypass grafting. J Cardiothorac Vasc Anes. 1999;13:150–3.
    1. Scholal C, Van Deenen D, De Ville A, Govearts MJ. Heart block following propofol in a child. Paediatr Anaesth. 1999;9:349–51.
    1. Egan TD, Brock-Utne JG. Asystole and anesthesia induction with a fentanyl, propofol and succinylcholine sequence. Anesth Analg. 1991;73:818–20.
    1. Shah S, Shah S, Apuya J, Gopalakrishnan S, Martin T. Combination of oral ketamine and midazolam as a premedication for a severely autistic and combative patient. J Anesth. 2009;23:126–8.
    1. White PF, Ham J, Way WL, Trevor AJ. Pharmacology of ketamine isomers in surgical patients. Anesthesiology. 1980;52:231–9.
    1. Chernow B, Laker CR, Creuss D, Coyle J, Hughes P, Balestrieri F, et al. Plasma, urine, and cerebrospinal fluid catecholamine concentration during and after ketamine sedation. Crit Care Med. 1982;10:600–3.
    1. Wayman K, Shoemaker WC, Lippmann M. Cardiovascular effects of anesthetic induction with ketamine. Anesth Analg. 1980;59:355–8.
    1. Spotoft H, Korshin JD, Sorensen MB, Skovsted P. The cardiovascular effects of ketamine used for induction of anesthesia in patients with valvular heart disease. Can Anesth Soc J. 1979;26:463–7.
    1. Gooding JM, Dimick AR, Travakoli M, Corssen G. A physiologic analysis of cardiopulmonary responses to ketamine anesthesia in non-cardiac patients. Anesth Analg. 1977;56:813–6.
    1. Fleischer F, Polarz H, Lang J, Bohrer H. Changes in oxygen saturation following low-dose intramuscular ketamine in pediatric cardiac surgical patients. Paediatric Anaesthesia. 1991;1:33–6.
    1. Mankikain B, Cantineau JP, Sartene R, Clergue F, Viars P. Ventilatory and chest wall mechanics during ketamine anesthesia in humans. Anesthesiology. 1986;65:492–9.
    1. Hirshman CA, Downes H, Farbood A, Bergman NA. Ketamine block of bronchospasm in experimental canine asthma. Br J Anaesth. 1979;51:713–8.
    1. Bourke DL, Malit LA, Smith TC. Respiratory interactions of ketamine and morphine. Anesthesiology. 1987;66:153–6.
    1. Lanning CF, Harmel MH. Ketamine anesthesia. Annu Rev Med. 1975;26:137–41.
    1. Taylor PA, Towey RM. Depression of laryngeal reflexes during ketamine administration. Br Med J. 1971;2:688–9.
    1. Cohen VG, Krauss B. Recurrent episodes of intractable laryngospasm during dissociative sedation with intramuscular ketamine. Pediatr Emerg Care. 2006;22:247–9.
    1. Melendez E, Bachur RP. Serious adverse events during procedural sedation with ketamine. Pediatr Emerg Care. 2009;25:325–8.
    1. Himmelseher S, Durieux ME. Revising a dogma: Ketamine for patients with neurological injury? Anesth Analg. 2005;101:524–34.
    1. Brown L, Christian-Kopp S, Sherwin TS, Khan A, Barcega B, Denmark TK, et al. Adjunctive atropine is unnecessary during ketamine sedation in children. Acad Emerg Med. 2008;15:314–8.
    1. Walthen JE, Roback MG, Mackenzie T, Bothner JP. Does midazolam alter the clinical effects of intravenous ketamine sedation in children. A double-blind, randomized controlled, emergency department trial? Ann Emerg Med. 2000;36:579–88.
    1. Van de Wiele B, Rubinstein E, Peacock W, Martin N. Propylene glycol toxicity caused by prolonged etomidate infusion. J Neurosurg Anesthesiol. 1995;7:259–62.
    1. Belelli D, Pistis M, Peters JA, Lambert JJ. The interaction of general anesthetics and neurosteroids with GABAA and glycine receptors. Neurochem Int. 1999;34:447–52.
    1. Giese JL, Stockham RJ, Stanley TH, Pace NL, Nelissen RH. Etomidate versus thiopental for induction of anesthesia. Anesth Analg. 1985;64:871–6.
    1. Brussel T, Theissen JL, Vigfusson G, Lunkenheimer PP, Van Aken H, Lawin P. Hemodynamic and cardiodynamic effects of propofol and etomidate: Negative inotropic properties of propofol. Anesth Analg. 1989;69:35–40.
    1. Wagner RL, White PF, Kan PB, Rosenthal MH, Feldman D. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med. 1984;310:1415–21.
    1. Absalom A, Pledger D, Konig A. Adrenocortical function in critically ill patients 24 hours after a single dose of etomidate. Anaesthesia. 1999;54:861–7.
    1. Cotton BA, Guillamondegui OD, Fleming SB, Carpenter RO, Patel SH, Morris JA, Jr, et al. Increased risk of adrenal insufficiency following etomidate exposure in critically injured patients. Arch Surg. 2008;143:62–7.
    1. Vinson DR, Bradbury DR. Etomidate for procedural sedation in emergency medicine. Ann Emerg Med. 2002;39:592–8.
    1. Rubin JT, Towbin RB, Bartko M, Baskin KM, Cahill AM, Kaye RD. Oral and intravenous caffeine for treatment of children with post-sedation paradoxical hyperactivity. Pediatr Rad. 2004;34:980–4.
    1. Holst JJ. Use of nitrous oxide-oxygen analgesia in dentistry. Int Dent J. 1962;12:47–51.
    1. Griffin GC, Campbell VD, Joni R. Nitrous oxide-oxygen sedation for minor surgery: Experience in a pediatric setting. JAMA. 1981;245:2411–4.
    1. Litman RS, Berkowitz RJ, Ward DS. Levels of consciousness and ventilatory parameters in young children during sedation with oral midazolam and nitrous oxide. Arch Pediatr Adolesc Med. 1996;150:671–5.
    1. Zier JL, Drake GJ, McCormick PC, Clinch KM, Cornfield DN. Case-series of nurse-administered nitrous oxide for urinary catheterization in children. Anesth Analg. 2007;104:876–9.
    1. Babl FE, Oakley E, Puspitadewi A, Sharwood LN. Limited analgesic efficacy of nitrous oxide for painful procedures in children. Emerg Med J. 2008;25:717–21.
    1. Mayers DJ, Hindmarsh KW, Sankaran K, Gorecki DK, Kasian GF. Chloral hydrate disposition following single-dose administration to critically ill neonates and children. Dev Pharmacol Ther. 1992;19:141–6.
    1. Graham SR, Day RO, Lee R, Fulde GW. Overdose with chloral hydrate: A pharmacological and therapeutic review. Med J Aust. 1988;149:686–8.
    1. Seger D, Schwartz G. Chloral hydrate: A dangerous sedative for overdose patients. Pediatri Emerg Care. 1994;10:349–50.
    1. Coté CJ, Karl HW, Notterman DA, Weinberg JA, McCloskey C. Adverse sedation events in pediatrics: Analysis of medications used for sedation. Pediatrics. 2000;106:633–44.
    1. Doyle WL, Perrin L. Emergence delirium in a child given oral midazolam for conscious sedation. Ann Emerg Med. 1994;24:1173–5.
    1. Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia. 1999;54:1136–42.
    1. Talke P, Chen R, Thomas B, Aggarwall A, Gottlieb A, Thorborg P, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000;90:834–9.
    1. Berkenbosch JW, Tobias JD. Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med. 2003;4:203–5.
    1. Hall JE, Uhrick TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90:699–705.
    1. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans: I Sedation, ventilation and metabolic rate. Anesthesiology. 1992;77:1125–33.
    1. Guidelines for the elective use of conscious sedation, deep sedation, and general anesthesia in pediatric patients, Committee on Drugs, Section on Anesthesiology. Pediatrics. 1985;76:317–21.
    1. American Academy of Pediatrics, Committee on Drugs: Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures. Pediatrics. 1992;89:1110–5.
    1. Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: An update. Pediatrics. 2006;118:2587–602.
    1. Practice guidelines for sedation and analgesia by non-anesthesiologists: A report by the American Society of Anesthesiologists Task Force on sedation and analgesia by non-anesthesiologists. Anesthesiology. 1996;84:459–71.
    1. Moyle JT. Uses and abuses of pulse oximetry. Arch Dis Child. 1996;74:77–80.
    1. Malviya S, Reynolds PI, Voepel-Lewis T, Siewert M, Watson D, Tait AR, et al. False alarms and sensitivity of conventional pulse oximetry versus the Masimo SET TM technology in the pediatric postanesthetic care unit. Anesth Analg. 2000;90:1336–40.
    1. Mannheimer PD, Bebout DE. The OxiMax system: Nellcor's new platform for oximetry. Minerva Anestesiol. 2002;68:236–9.
    1. Hart LS, Berns SD, Houck CS, Boenning DA. The value of end-tidal CO2 monitoring when comparing three methods of conscious sedation for children undergoing painful procedures in the emergency department. Pediatr Emerg Care. 1997;13:189–93.
    1. Tobias JD. End-tidal carbon dioxide monitoring during sedation with a combination of midazolam and ketamine for children undergoing painful, invasive procedures. Pediatr Emerg Care. 1999;15:173–5.
    1. Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, et al. Validity and reliability of the observer's assessment of alertness/sedation scale: Study with intravenous midazolam. J Clin Psychopharmacol. 1990;10:244–51.
    1. Macnab AJ, Levine M, Glick N, Susak L, Baker-Brown G. A research tool for measurement of recovery from sedation: The Vancouver Sedative Recovery Scale. J Pediatr Surg. 1991;26:1263–7.
    1. Malviya S, Voepel-Lewis T, Tait AR, Merkel S, Tremper K, Naughton N. Depth of sedation in children undergoing computed tomography: Validity and reliability of the University of Michigan Sedation Scale (UMSS) Br J Anaesth. 2002;88:241–5.
    1. Gill M, Green SM, Krauss B. A study of the Bispectral Index Monitor during procedural sedation and analgesia in the emergency department. Ann Emerg Med. 2003;41:234–41.
    1. McDermott NB, VanSickle T, Motas D, Friesen RH. Validation of the Bispectral Index monitor during conscious and deep sedation in children. Anesth Analg. 2003;97:39–43.
    1. Motas D, McDermott NB, VanSickle T, Friesen RH. Depth of consciousness and deep sedation attained in children as administered by nonanesthesiologists in a children's hospital. Pediatr Anesth. 2004;14:256–60.
    1. Davidson AJ, Kim MJ, Sangolt GK. Entropy and bispectral index during anaesthesia in children. Anaesth Intensive Care. 2004;32:485–93.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren